Correlation Between Crinetics Pharmaceuticals and Aurora Cannabis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Aurora Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Aurora Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Aurora Cannabis, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Aurora Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Aurora Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Aurora Cannabis.

Diversification Opportunities for Crinetics Pharmaceuticals and Aurora Cannabis

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Crinetics and Aurora is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Aurora Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aurora Cannabis and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Aurora Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aurora Cannabis has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Aurora Cannabis go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Aurora Cannabis

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.92 times more return on investment than Aurora Cannabis. However, Crinetics Pharmaceuticals is 1.09 times less risky than Aurora Cannabis. It trades about -0.08 of its potential returns per unit of risk. Aurora Cannabis is currently generating about -0.15 per unit of risk. If you would invest  6,001  in Crinetics Pharmaceuticals on September 12, 2024 and sell it today you would lose (284.00) from holding Crinetics Pharmaceuticals or give up 4.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  Aurora Cannabis

 Performance 
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Crinetics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Aurora Cannabis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aurora Cannabis has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Crinetics Pharmaceuticals and Aurora Cannabis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crinetics Pharmaceuticals and Aurora Cannabis

The main advantage of trading using opposite Crinetics Pharmaceuticals and Aurora Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Aurora Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aurora Cannabis will offset losses from the drop in Aurora Cannabis' long position.
The idea behind Crinetics Pharmaceuticals and Aurora Cannabis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Transaction History
View history of all your transactions and understand their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity